Ainur Eleusizova

Ainur Eleusizova

Auto-generated profile, based on publicly available information

Ainur Eleusizova

Center of Phthisiopulmonology Almaty , Almaty

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2025 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
JBJuliana G E Bartels
Juliana G E Bartels
NTNurlan Takenov
Nurlan Takenov
LCLyailya Chingissova
Lyailya Chingissova
ARAnar Rakisheva
Anar Rakisheva
AEAinur Eleusizova
Ainur Eleusizova
YAYanis Ben Amor
Yanis Ben Amor
Background: Rapid, accurate detection of Mycobacterium tuberculosis and drug resistance is crucial to reduce tuberculosis (TB) burden and prevent development of drug resistance in high-burden drug-resistant TB regions. Methods: From December 2021 to July 2022, sputum samples from 1214 adult patients with presumptive TB in Almaty, Kazakhstan, were tested by BD MAX MDR-TB (Becton Dickinson), Cepheid Xpert MTB/RIF, and mycobacterial growth indicator tube (MGIT) liquid culture for detection of TB and drug resistance to rifampicin (RIF) and isoniazid (INH). Results: When compared with MGIT, BD MAX sensitivity and specificity for TB detection were 90% and 87%, and Xpert MTB/RIF results were 86% and 92%. For RIF resistance, BD MAX sensitivity and specificity were 91% and 95%, and Xpert MTB/RIF results were 94% and 92%. For INH resistance, BD MAX sensitivity and specificity were 98% and 97%. Whole genome sequencing was conducted for 24 samples with discordant RIF resistance results among the 3 devices to determine mutations related to resistance. When compared with a composite standard based on whole genome sequencing and MGIT, Xpert MTB/RIF had higher sensitivity and specificity for RIF resistance than BD MAX. Conclusions: Countries with high burden of drug-resistant TB should carry out national prevalence surveys to assess rates of multidrug-resistant TB and INH monoresistance. Those with higher rates should consider adopting BD MAX due to its ability to accurately diagnose RIF and INH resistance.